Chronic Kidney Disease Stage 2 Clinical Trial
Vitamin D Supplement in patients with CKD stage 1 and 2 may change osteoprotegin expression so as to produce beneficial effects of cardiovascular、bone metabolism and CKD progression.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05169411 -
Preserving Kidney Function in Children With Chronic Kidney Disease
|
N/A | |
| Completed |
NCT05630729 -
Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management
|
N/A | |
| Active, not recruiting |
NCT04960514 -
Prospective Decision Impact Trial of KidneyIntelX
|
||
| Active, not recruiting |
NCT05198284 -
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
|
||
| Active, not recruiting |
NCT05225454 -
The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques
|
||
| Recruiting |
NCT01820195 -
N-Acetyl Cystein and Contrast Nephropathy
|
Phase 3 | |
| Completed |
NCT04617431 -
Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients
|
N/A |